(1R,7S,9aR,11aR)-3a-(1-hydroxyprop-2-enyl)-6,6,9a,11a-tetramethyl-1-(6-methylheptan-2-yl)-1,2,4,5,5a,7,8,9,10,11-decahydronaphtho[1,2-g][1]benzofuran-7-ol | 199480-80-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (1R,7S,9aR,11aR)-3a-(1-hydroxyprop-2-enyl)-6,6,9a,11a-tetramethyl-1-(6-methylheptan-2-yl)-1,2,4,5,5a,7,8,9,10,11-decahydronaphtho[1,2-g][1]benzofuran-7-ol
• CAS: 199480-80-3
• 化学式: C₃₁H₅₂O₃
• 分子量: 472.7
• InChiKey: KIOUIMVIZXYLFV-BRFIBAHXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
  申请人：Keller T. Bradley

  公开号：US20060003975A1

  公开（公告）日：2006-01-05

  Novel methods and combinations for the treatment and/or prophylaxis of a pathologic condition in a subject, wherein the methods comprise the administration of one or more HMG Co-A reductase inhibitors and one or more aldosterone receptor antagonists, and the combinations comprise one or more HMG Co-A reductase inhibitors and one or more of said aldosterone receptor antagonists.

  用于治疗和/或预防受试者病理状况的新方法和组合，其中所述方法包括施用一种或多种 HMG Co-A 还原酶抑制剂和一种或多种醛固酮受体拮抗剂，所述组合包括一种或多种 HMG Co-A 还原酶抑制剂和一种或多种所述醛固酮受体拮抗剂。
• COMBINATION OF AN ALDOSTERONE RECEPTOR ANTAGONIST AND AN HMG COA REDUCTASE INHIBITOR
  申请人：Pharmacia Corporation

  公开号：EP1406660B1

  公开（公告）日：2007-06-06
• Compositions and methods for treatment of viral diseases
  申请人：Johansen Lisa M.

  公开号：US20100092479A1

  公开（公告）日：2010-04-15

  The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E).
• COMPOSITIONS AND METHODS FOR TREATMENT OF FILOVIRUS-MEDIATED DISEASES
  申请人：Johansen Lisa M.

  公开号：US20110028564A1

  公开（公告）日：2011-02-03

  The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
• US8475804B2
  申请人：——

  公开号：US8475804B2

  公开（公告）日：2013-07-02